GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PreveCeutical Medical Inc (XCNQ:PREV) » Definitions » EBITDA Margin %

PreveCeutical Medical (XCNQ:PREV) EBITDA Margin % : 0.00% (As of Sep. 2023)


View and export this data going back to 2016. Start your Free Trial

What is PreveCeutical Medical EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. PreveCeutical Medical's EBITDA for the three months ended in Sep. 2023 was C$-0.16 Mil. PreveCeutical Medical's Revenue for the three months ended in Sep. 2023 was C$0.00 Mil. Therefore, PreveCeutical Medical's EBITDA margin for the quarter that ended in Sep. 2023 was 0.00%.


PreveCeutical Medical EBITDA Margin % Historical Data

The historical data trend for PreveCeutical Medical's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PreveCeutical Medical EBITDA Margin % Chart

PreveCeutical Medical Annual Data
Trend Jul15 Jul16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
EBITDA Margin %
Get a 7-Day Free Trial -75,593.33 -94,466.67 - - -

PreveCeutical Medical Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Sep23
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of PreveCeutical Medical's EBITDA Margin %

For the Biotechnology subindustry, PreveCeutical Medical's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PreveCeutical Medical's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PreveCeutical Medical's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where PreveCeutical Medical's EBITDA Margin % falls into.



PreveCeutical Medical EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

PreveCeutical Medical's EBITDA Margin % for the fiscal year that ended in Dec. 2022 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2022 )/Revenue (A: Dec. 2022 )
=-1.234/0
= %

PreveCeutical Medical's EBITDA Margin % for the quarter that ended in Sep. 2023 is calculated as

EBITDA Margin %=EBITDA (Q: Sep. 2023 )/Revenue (Q: Sep. 2023 )
=-0.157/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PreveCeutical Medical  (XCNQ:PREV) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


PreveCeutical Medical EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of PreveCeutical Medical's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


PreveCeutical Medical (XCNQ:PREV) Business Description

Traded in Other Exchanges
Address
885 Cambie Street, Suite 2500, Vancouver, BC, CAN, V6B 0R6
PreveCeutical Medical Inc is a health sciences company. Its principal business activity is the development of innovative options for preventive and curative therapies utilizing organic and nature-identical products. It is engaged in licensing, branding, and marketing nutraceutical and wellness products.

PreveCeutical Medical (XCNQ:PREV) Headlines

No Headlines